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Abstract
Huntington’s disease (HD) is caused by CAG repeat expansion in exon 1 of a large gene, IT15, possessing 67 exons.
Transgenic mice expressing a truncated N-terminal peptide of huntingtin with an expanded polyglutamine tract translated
only from exon 1 develop symptoms similar to Huntington’s disease. In the present study, a bacterial system (Escherichia
coli) was used to express truncated peptides of huntingtin translated from exon 1 of the HD gene. Bacterial death was
observed after the induction of peptides with expanded polyglutamine tracts, and both sodium dodecyl sulfate (SDS)-soluble
peptides and insoluble aggregated material were detected by immunoblotting in the homogenates of such E. coli. E. coli death
was partially reduced by the addition of dimethylsulfoxide (DMSO) or glycerol to the medium, with a consequent decrease in
aggregated material and an increase in SDS-soluble peptide in the homogenate. These results suggest that DMSO and
glycerol may decrease the toxicity of huntingtin with expanded polyglutamine tracts by acting as chemical
chaperones. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Huntington’s disease (HD) is an autosomal domi-
nant progressive neurodegenerative disorder caused
by dynamic mutation; namely expansion of the
CAG repeat on exon 1 of the HD gene [1], which
translates into a polyglutamine tract in the protein
now known as huntingtin. Eight diseases have been
reported to be caused by expansion of polyglutamine
tracts [2^11] and the molecular mechanisms of these
diseases are believed to be identical. Mangiarini et al.
[12] reported that transgenic mice containing a
V1 kb sequence of native human promoter and
exon 1 of the human HD gene with the expanded
CAG repeat develop symptoms very similar to those
of HD, although the mice only express a truncated
N-terminal peptide of huntingtin (tN-htt) that har-
bors an expanded polyglutamine tract. Furthermore,
they reported that the characteristic nuclear inclu-
sions (NIs) reported in the brains of HD patients
[13] are observed in the neurons of transgenic mice
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[14]. NIs have been reported in the brains of patients
with SCA1 [15], SCA3 [16], SBMA [17], DRPLA [18]
and SCA7 [19], as well as in the brain of a transgenic
SCA1 mouse [20] and in the eye cells of Drosophila
containing a transgene of SCA3 [21]. NIs are now
thought to be a common feature of diseases caused
by expansion of polyglutamine tracts. Moreover,
Onodera et al. [22] reported that Escherichia coli ex-
pressing GST-fusion protein containing an expanded
polyglutamine tract derived from DRPLA protein do
not replicate while those expressing fusion protein
with normal polyglutamine do. They described this
phenomenon as being ‘‘synonymous with cell death
of E. coli’’. These ¢ndings suggest that at the molec-
ular level a common pathophysiology may be in-
volved in the brains of patients with polyglutamine
diseases, in corresponding transgenic mice and even
in E. coli, despite bacteria lacking a nucleus.
Although whether NIs directly cause neuronal death
remains unclear, the aggregated form of the peptide
with an expanded polyglutamine tract is thought to
be a major component in the formation of NIs. Re-
cently, Cummings et al. [23] reported that co-expres-
sion of ataxin-1 with an expanded polyglutamine
tract and one of the chaperones, HDJ-2/HSDJ, in
HeLa cells decreases the frequency of ataxin-1 aggre-
gation. They suggested that this molecular chaperone
may protect ataxin-1 from misfolding and aggrega-
tion. Dimethylsulfoxide (DMSO) and glycerol have
been known to have chaperone-like e¡ects and Tat-
zelt et al. [24] reported that these reagents may inter-
fere with the formation of an insoluble form of mu-
tated prion protein.
In the present investigation, an E. coli system was
used as a model for expression of tN-htt with an
expanded polyglutamine tract and for the further
study of its role in cell death. We observed a decrease
in the OD600 of bacterial clones expressing tN-htt
with an expanded polyglutamine tract after peptide
induction, and bacterial death was con¢rmed by dif-
ferential staining of live and dead bacteria. On im-
munoblots, both insoluble aggregated materials and
SDS-soluble forms of tN-htt with an expanded poly-
glutamine tract were detected in the homogenates.
We also found that this cell death was partially re-
duced by the addition of DMSO or glycerol, and a
decrease in the aggregated form and an increase in
the SDS-soluble form of tN-htt were observed.
2. Materials and methods
2.1. Bacterial strain and vectors
Competent BL21(DE3)pLysS bacteria and expres-
sion vector pET11d were purchased from Stratagene.
The fragments of the HD gene used were NcoI^ApaI
fragments with (CAG)23, (CAG)48, (CAG)80 or
(CAG)113 isolated from phage genomic clones de-
rived from HD patients and normal controls. These
fragments contained the whole open reading frame
of exon 1, and had a stop codon just after the exon^
intron boundary in the same reading frame as the
initiation codon. These fragments were inserted into
the cloning site of the pET11d vector. Transforma-
tion of the competent E. coli was performed accord-
ing to the heat shock method.
2.2. Names of E. coli clones and tN-htt
A CAACAG sequence occurs just after the CAG
repeat in the HD gene. Both CAA and CAG are
translated to glutamine residues, and two polyglut-
amines more are found in translated tN-htt than in
the CAG repeat. Thus, E. coli clones containing
pET11d-HD gene exon 1 with (CAG)23, (CAG)48,
(CAG)80 and (CAG)113 and the pET11d vector
alone were abbreviated as E-Q25, E-Q50, E-Q82,
E-Q115 and E-Mock, respectively. TN-htt expressed
in E-Q25, E-Q50, E-Q82 and E-Q115 were abbrevi-
ated as HQ25, HQ50, HQ82 and HQ115, respec-
tively.
2.3. IPTG-mediated induction of tN-htt and the
monitoring of bacterial growth
Each E. coli clone was cultured in LB medium
containing 50 WM ampicillin and 34 WM chloramphe-
nicol at 37‡C with vigorous shaking overnight. One
hundredth of the volume of the bacterial culture was
then added to LB medium containing 200 WM ampi-
cillin and 34 WM chloramphenicol and cultured with
vigorous shaking at 37‡C until the OD600 reached
0.4 þ 0.02. Subsequently, 1 mM IPTG (isopropyl-1-
thio-L-D-galactoside) was added to the medium to
induce peptide expression. The growth of E. coli
was monitored by measuring OD600 at 1, 2, 3 and
4 h.
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2.4. Evaluation of bacterial viability
A LIVE/DEAD BacLight kit (L-7007) was pur-
chased from Molecular Probes. A 50 Wl aliquot of
the bacterial culture was centrifuged at 10 000Ug for
1 min and the pellet was resuspended in 1 ml Milli-Q
water with 3 Wl staining reagent. After brief vortex-
ing, the bacterial suspension was kept at room tem-
perature for 15 min. An Arbo 1420 Multilabel coun-
ter (Wallac) was used to measure £uorescence
intensity. The excitation wavelength was 485 nm
and the emission wavelength for live bacteria was
535 nm and for dead bacteria 642 nm.
2.5. Administration of DMSO and glycerol
DMSO or glycerol was added to the culture me-
dium simultaneously at peptide induction. The con-
centrations of these reagents were determined ac-
cording to Tatzelt et al. [24]. E-Q115 was used to
evaluate the e¡ects of 100^500 mM DMSO and the
e¡ects of 100^500 mM glycerol on growth, by mon-
itoring of OD600. The OD600 of E-Mock grown in the
presence of DMSO or glycerol was also monitored.
2.6. Transfection of mammalian cells
A mammalian expression vector, pRcCMV, was
purchased from Invitrogen. HD gene exon 1 with
(CAG)113 was inserted into the multiple cloning
site of pRcCMV to express HQ115 in mammalian
cells (pRcCMV-HQ115). Both COS-7 cells and 293
cells were cultured in DMEM containing 10% fetal
bovine serum in 35 mm plates. Transfection was per-
formed with 1 Wg pRcCMV-HQ115 using lipofect-
amine (Gibco-BRL) when cells were around 70%
con£uent. Cells were cultured further and harvested
48 h after transfection.
2.7. Immunochemical detection of tN-htt
Anti-polyglutamine monoclonal antibody, 1C2,
was purchased from Chemicon. To raise polyclonal
anti-N-terminal antibodies, the following procedure
was undertaken at our request by Sawady Tech. Co.
(Tokyo, Japan): a 17 amino acid peptide of the N-
terminal portion of huntingtin was chemically
bridged to produce MAP antigens and two rabbits
were then immunized with these antigens. Anti-se-
rum was applied to an a⁄nity column that bound
the N-terminal 17 amino acid peptide and then
eluted. The puri¢ed antibody was designated HD-
N2. For immunoblotting and the ¢lter retardation
assay, HD-N2 was used at a 1:250 dilution and
1C2 was used at a 1:2000 dilution. For immunoblot-
ting, 1 ml of bacterial culture of each clone was har-
vested and centrifuged at 10 000Ug for 1 min. Each
pellet was washed with phosphate-bu¡ered saline
(PBS) once and then sample bu¡er (50 mM Tris^
HCl pH 6.8, 2% SDS, 8% L-mercaptoethanol and
10% glycerol) was added directly to the pellet to
avoid in vitro aggregation of tN-htt. Brief (5 s) and
weak sonication was performed to produce an homog-
enate and the samples were then boiled for 5 min.
Another bacterial pellet prepared from the same bac-
terial culture was suspended in suspension bu¡er
(100 mM NaCl, 10 mM Tris^HCl pH 7.8, 1 mM
EDTA) and then sonicated thoroughly and the ho-
mogenate was utilized for the protein assay. The
protein concentration of this homogenate was deter-
mined using the BCA assay kit (Pierce). The gel used
for SDS^polyacrylamide gel electrophoresis was a
10^20% gradient gel without stacking (Multi Gel
10/20) purchased from Daiichi Pure Chemicals Co.
(Tokyo, Japan). For immunoblotting, a polyvinyl-
idene-di£uoride (PVDF) membrane (Immobilon,
Millipore) was used. For detection, ECL (Amer-
sham) was used and the signal was detected by ex-
posing the membrane to X-ray ¢lm.
2.8. Filter retardation assay
To evaluate the amount of the aggregated form of
tN-htt, the same basic procedure as that for the ¢lter
retardation assay reported by Sittler et al. [25] was
used. A 1 ml aliquot of the bacterial culture of each
clone was harvested and centrifuged at 10 000Ug for
1 min. Each pellet was washed with PBS once and
then suspended in suspension bu¡er (100 mM NaCl,
10 mM Tris^HCl pH 7.8, 1 mM EDTA). This sus-
pension was then sonicated thoroughly and centri-
fuged at 15 000Ug for 5 min. The pellet, which con-
tained the insoluble material, was resuspended in 100
Wl DNAse bu¡er (10 mM Tris^HCl, pH 7.5, and 10
mM MgCl2) and the protein concentration was de-
termined using the BCA assay kit (Pierce). Then
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DNAse I was added to a ¢nal concentration of 1 mg/
ml followed by incubation at 37‡C for 1 h. After
DNAse treatment, a sample containing 5 Wg protein
was diluted into 100 Wl of 1% SDS and 8% L-mer-
captoethanol in PBS, boiled for 5 min and ¢ltered
through a cellulose acetate membrane (Schleicher
and Schuell, 0.2 Wm pore size) using a Gibco-BRL
dot-blot ¢ltration unit. After ¢ltration, two washes
were performed with 200 Wl of 0.1% SDS. The cellu-
lose acetate membrane was processed for immunode-
tection using HD-N2 in the same way as PVDF
membranes in regular immunoblotting. Signals on
X-ray ¢lm were quanti¢ed using the densitometric
method and were evaluated with Mac Scope (Mitani
Co.) software for image analysis.
3. Results
3.1. Bacterial growth after IPTG-mediated induction
of tN-htt
The OD600 of every clone increased after 1 h, and
then the OD600 of E-Q50, E-Q82 and E-Q115 began
to decrease, while the OD600 of E-Q25 and E-Mock
continued to increase (Fig. 1). Stringy clumps of
lysed bacterial debris were observed microscopically
in the medium of E-Q50, E-Q82 and E-Q115 after 3 h
(data not shown). The OD600 of E-Q50, E-Q82 and
E-Q115 began to increase after 3 to 4 h.
3.2. Evaluation of bacterial viability
Cellular counts of live and dead bacteria were then
evaluated at £uorescence intensities of 535 nm (F535)
and 642 nm (F642), respectively (Fig. 2a,b). The F642
of E-Q50, E-Q82 and E-Q115 were highest 2 h after
peptide induction, after which they decreased owing
Fig. 1. Growth of E-Q25, E-Q50, E-Q82, E-Q115 and E-Mock
monitored by OD600 after peptide induction. The OD600 of E-
Q50, E-Q82 and E-Q115 decreased after 2 h. Data represent
mean þ S.E.M. (n = 5). (F) E-Mock, (b) E-Q25, (E) E-Q50, (a)
E-Q82, (O) E-Q115.
Fig. 2. The intensity of £uorescence of bacteria stained with
LIVE/DEAD BacLight was monitored at 535 nm (F535) for live
cells (a) and 642 nm (F642) for dead cells (b). The F642 of E-
Q50, E-Q82 and E-Q115 was highest 2 h after peptide induc-
tion, after which it decreased in number due of bacteriolysis.
Data represent mean þ S.E.M. (n = 3). (F) E-Mock, (b) E-Q25,
(E) E-Q50, (a) E-Q82, (O) E-Q115. (c) The ratio of F535 :F642
of each clone at 2 h is shown. Error bars indicate S.E.M.
(n = 4). The data were statistically evaluated using one-way AN-
OVA followed by Fisher’s post hoc analysis for multiple com-
parisons. (**P6 0.01, ***P6 0.001)
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to the large number of dead cells that were lysed.
The ratios of F535 :F642, which represent the ratios
of live to dead cells 2 h after peptide induction are
shown in Fig. 2c.
3.3. Immunochemical detection of tN-htt
Total homogenates of each bacterial clone at 0, 1,
2, 3, 4 and 20 h after peptide induction were ana-
lyzed by immunoblotting using HD-N2 as the pri-
mary antibody and 40 Wg of protein. Expressed pep-
tides were detected on the membranes (Fig. 3,
upper). Only HQ25 could be detected at the expected
size of 10 kDa. In the HQ50, HQ82 and HQ115
lanes, insoluble material at the top of the gel was
recognized by HD-N2. Therefore HQ50, HQ82 and
HQ115 were considered to cause aggregates that
stacked at the top of the gel. The amount of stacked
material di¡ered between the three
(HQ506HQ826HQ115), whilst the timing of ap-
pearance also di¡ered (¢rst HQ115, second HQ82
and third HQ50). The same samples were analyzed
using 1C2, which recognizes only the expanded poly-
glutamine tract [26], and HQ50, HQ82 and HQ115
were all detected (Fig. 3, lower). HQ50 consisted of a
major band 25 kDa in size and faint bands of larger
or smaller size. HQ82 migrated as 31 to 33 kDa
bands and the size of HQ82 seemed to increase grad-
ually. HQ115 migrated as fuzzy bands and seemed to
consist of a major band 40 kDa in size and a faint
larger sized band. There were no signals at the top of
any of the lanes. To con¢rm whether HD-N2 and
1C2 detect the same protein, cell lysates of COS-7
cells and 293 cells transfected with pRcCMV-HQ115
as well as the homogenate of E-Q115 were analyzed
by immunoblotting (Fig. 4). In this study 100 Wg
protein was used and a longer exposure was given
for the detection of HQ-115. As shown in Fig. 4,
both HD-N2 and 1C2 react with the 40 kDa band
of HQ115 expressed in bacteria, while HD-N2 can-
not detect HQ115 expressed in COS-7 cells and 293
cells.
Fig. 3. Upper: Total homogenates of each clone at 0, 1, 2, 3, 4 and 20 h after peptide induction were analyzed by immunoblotting us-
ing anti N-terminal antibodies, HD-N2. Only HQ25 was detected, as a 10 kDa band, at the expected molecular weight (arrowhead).
In the HQ50, HQ82 and HQ115 lanes, insoluble material at the gel top was observed. Non-speci¢c reactants are indicated by open ar-
rowheads. The gel was a 10^20% gradient gel. Lower: The same samples were analyzed using the monoclonal anti-polyglutamine anti-
body, 1C2. HQ50, HQ82 and HQ115 were detected as 25, 32 and 40 kDa bands, respectively (arrowheads), but there was no signal
in the HQ25 lane or at the top of the gel for all lanes. Non-speci¢c reactants are indicated by an open arrowhead.
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3.4. E¡ects of DMSO and glycerol on bacterial
growth
The changes in the OD600 of E-Mock and E-Q115
upon administration of DMSO or glycerol are shown
in Fig. 5. DMSO at the higher concentrations pro-
duced inhibitory e¡ects on the growth of E-Mock
(Fig. 5a) and E-Q115 (Fig. 5b), whereas DMSO pro-
tected E-Q115 from a decrease in OD600 at 2 h and
every timepoint thereafter (Fig. 5b). A 100 to 500
mM glycerol concentration had a protective e¡ect
on the growth of E-Q115 (Fig. 5d).
3.5. E¡ects of DMSO and glycerol on bacterial
viability
Cell viability was assessed using the ratio of
F535 :F642 following administration of 250 mM
DMSO or 100 mM glycerol (Fig. 6). As shown in
Fig. 6, 250 mM DMSO increased the cell viability of
E-Q25, E-Q50, E-Q82 and E-Q115, and 100 mM
glycerol increased the cell viability of all clones.
3.6. Immunochemical evaluation of the e¡ects of
DMSO and glycerol on tN-htt
To evaluate the e¡ects of DMSO and glycerol on
the aggregated form of tN-htt, a ¢lter retardation
assay of HQ115 expressed 2 h after induction was
performed using HD-N2 (Fig. 7a). To evaluate these
e¡ects on the SDS-soluble form of tN-htt, immuno-
Fig. 5. The e¡ect of DMSO was evaluated using E-Mock (a)
and E-Q115 (b) by monitoring OD600. The e¡ect of glycerol
was also evaluated using E-Mock (c) and E-Q115 (d). DMSO
of high concentration had some inhibitory e¡ect on the growth
of both E-Mock and E-Q115, but protected E-Q115 from a de-
crease in OD600 at 2 h and thereafter. 100^500 mM glycerol
had a protective e¡ect on the growth of E-Q115. Data repre-
sent mean þ S.E.M. (n = 3). (F) none, (E) 100 mM, (a) 250
mM, (O) 500 mM.
Fig. 6. The ratio of F535 :F642 of each clone without reagents
(white columns), with 250 mM DMSO (black columns) and
with 100 mM glycerol (hatched columns) at 2 h is shown. Error
bars indicate S.E.M. (n = 5). The data were examined using
one-tailed paired Student’s t-test comparing data with and with-
out reagent. (*P6 0.05, **P6 0.01, ***P6 0.001)
Fig. 4. Homogenates of COS-7 cells (lanes 1, 4), 293 cells (lanes
2, 5) and E-Q115 (lanes 3, 6) were analyzed with 1C2 (lanes 1^
3) and HD-N2 (lanes 4^6). SDS-soluble forms of HQ115 were
detected as the same size (40 kDa) in mammalian cells and in
E. coli, although the amount of protein in COS-7 cells and 293
cells was too little to be detected with HD-N2 (lane 4, 5).
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blotting of 10 Wg of HQ115 expressed in the presence
of 100^500 mM DMSO or 100^500 mM glycerol was
performed using 1C2 (Fig. 7c). As shown in Fig. 7a,
DMSO and glycerol decreased the amount of the
aggregated form of HQ115. These e¡ects were con-
¢rmed statistically (Fig. 7b). DMSO and glycerol
also appeared to increase the amount of the SDS-
soluble form of HQ115 (Fig. 7c).
4. Discussion
The mechanism by which mutant huntingtin indu-
ces neurodegeneration is unknown. While several eu-
karyotic cell-based models have been established to
study this mechanism, bacterial cells, like E. coli, are
also powerful tools with which to study the mecha-
nism of this cell death. In the present study, E. coli
clones expressing HQ50, HQ82 and HQ115 were be-
lieved dead given that the OD600 decreased after pep-
tide induction, indicating a decrease in cell numbers,
and because LIVE/DEAD BacLight staining con-
¢rmed that a large number of the cells were dead.
The LIVE/DEAD BacLight kit utilizes a mixture of
SYTO 9 green £uorescent nucleic acid stain and the
red £uorescent nucleic acid stain, propidium iodide.
These stains di¡er both in their spectral character-
istics and in their ability to penetrate healthy bacte-
rial cells. When used alone, SYTO 9 stain generally
labels all bacteria in a population, both those with
Fig. 7. (a) A ¢lter retardation assay of HQ115 with 100^500 mM DMSO or with 100^500 mM glycerol, 2 h after induction was per-
formed using HD-N2. As a negative control HQ25 harvested at the same period was used. (b) Densitometric analysis of the ¢lter re-
tardation assays. Quanti¢ed data of the signal spots were statistically evaluated using one-way ANOVA followed by Fisher’s post hoc
analysis for multiple comparisons. (*P6 0.05, **P6 0.01) Error bars indicate S.E.M. (n = 7). (a) DMSO, (b) glycerol. (c) Immuno-
blots of HQ115 with 100^500 mM DMSO or 100^500 mM glycerol 2 h after induction were performed using 1C2 (arrowhead). These
experiments were performed three times with similar results. DMSO and glycerol appeared to increase the amount of the SDS-soluble
form.
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intact membranes and those with damaged mem-
branes. In contrast, propidium iodide penetrates
only bacteria with damaged membranes, causing a
reduction in the SYTO 9 stain £uorescence when
both dyes are present. Onodera et al. [22] reported
that E. coli expressing GST-fusion protein containing
an expanded polyglutamine tract derived from
DRPLA protein does not replicate after protein in-
duction. Using BL21(DE3)pLysS, the strain used in
the present study, they evaluated bacterial growth by
OD600 and found that the OD600 of E. coli expressing
GST-fusion protein with an expanded polyglutamine
tract did not increase after protein induction. They
also noted that such E. coli formed relatively fewer
colony forming units. In contrast with their report, in
the present study, the death of E. coli expressing
HQ50, HQ82 and HQ115 was more noticeable,
most likely because the tN-htt used here is smaller
than GST-fusion protein. Other studies have also
demonstrated that the cellular toxicity of peptides
with expanded polyglutamine tracts increases with a
corresponding decrease in protein size [27,28]. Not
all the bacterial clones expressing HQ50, HQ82 or
HQ115 were killed and they started to increase in
numbers again after 3 to 4 h. We also believe that
some clone revertants evaded cell death and became
dominant. In our study the length of the polyglut-
amine tract did not seem to correlate well with the
severity of cell death, for example the F535 :F642 at 2 h
after protein induction is lowest in E-Q50 and high-
est in E-Q115 (Fig. 2). Thus, it is plausible that the
revertants might appear faster in the clone expressing
a longer polyglutamine tract. The expression of
HQ25 also decreases bacterial viability and, thus,
even normal length polyglutamine tracts may be po-
tentially toxic for E. coli when over-expressed.
Whether E. coli can be used as a model for the
pathophysiology of human disorders is unclear.
However, many trials using prokaryotes have been
performed for just this purpose. For instance, Asoh
et al. [29] used E. coli to study cell death induced by
Bax, a eukaryotic apoptosis-inducing factor. They
reported that the E. coli died when human Bax was
expressed and that co-expression of anti-apoptotic
Bcl-x had an inhibitory e¡ect on the cell death of
these E. coli. This would seem to suggest that pro-
karyotes might be used under certain circumstances
to study higher organic processes such as apoptosis.
The results of the immunoblots shown in Fig. 3
are instructive. The insoluble aggregated material of
HQ50, HQ82 and HQ115 that formed at the top of
their lanes was considered to be aggregated forms of
tN-htt. These results correlate well with the clinical
knowledge that the number of CAG repeats of the
HD gene in patients is more than 35. When the ag-
gregated materials appeared and what they were
formed of di¡ered among HQ50, HQ82 and
HQ115, namely the longer the polyglutamine tract
became, the faster and the bigger the aggregates ap-
peared. Using the monoclonal antibody 1C2, which
recognizes only an expanded polyglutamine tract
[26], HQ50, HQ82 and HQ115 were detected in the
gel as SDS-soluble forms. SDS-soluble forms of
HQ50, HQ82 and HQ115 were, however, not de-
tected as discrete single bands, and it is possible
that they didn’t migrate uniformly in the SDS-poly-
acrylamide gel. Although they existed as SDS-soluble
forms in the gel, they were barely recognized by HD-
N2, possibly because the SDS-soluble forms of
HQ50, HQ82 and HQ115 are insu⁄cient in concen-
tration for recognition by HD-N2, while 1C2 is more
sensitive in recognizing the soluble forms of HQ50,
HQ82 and HQ115. When a lot of sample was loaded
onto the gel and a longer exposure time was given
for detection, the SDS-soluble form of tN-htt was
able to be detected even with HD-N2 (Fig. 4).
DMSO and glycerol are organic solvents that have
been known to stabilize proteins in their native con-
formation. In the present study, although DMSO
had some inhibitory e¡ect on the growth of E. coli,
DMSO appeared to protect E-Q50, E-Q82 and E-
Q115 from death. Glycerol did not have an inhibi-
tory e¡ect and seemed to have protective or stimula-
tive e¡ects on the growth of all clones. Both DMSO
and glycerol decreased the aggregated form of tN-htt
according to the ¢lter retardation assay, and the
SDS-soluble form of tN-htt increased upon addition
of either DMSO or glycerol to the medium. These
results indicate that DMSO and glycerol can inhibit
the formation of the aggregated form of tN-htt.
Chaperones are known to be involved in the path-
ophysiology of many diseases, particularly in prion
disease [30]. Tatzelt et al. [24] reported that both
DMSO and glycerol may interfere with the forma-
tion of an insoluble form of mutated prion protein
and they call these reagents ‘chemical chaperones’.
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The results of the present study appear to support
this idea of chemical chaperones as a mechanism for
the observed e¡ects of DMSO and glycerol. Thus, a
search for reagents with a chaperone-like e¡ect and
with lower toxicity than DMSO and glycerol may
lead to the discovery of treatments for CAG repeat
diseases.
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